PGK1在肿瘤中的研究进展
Research Progress of PGK1 in Tumor
DOI: 10.12677/ACM.2022.1291230, PDF,    科研立项经费支持
作者: 李钰婵：西安医学院，陕西 西安；张 薇, 杨淑梅*：陕西省人民医院呼吸与危重症医学科，陕西 西安；兀 威：西安医学院第二附属医院呼吸与危重症医学科，陕西 西安
关键词: 磷酸甘油激酶1；糖酵解；肿瘤；Phosphoglycerate Kinase 1； Glycolysis； Cancer
摘要: 磷酸甘油激酶1 (PGK1)是糖酵解过程中产生ATP的第一个关键代谢酶，参与肿瘤的糖酵解途径。PGK1不仅可以作为一种代谢酶，影响肿瘤生长，也可以通过其非代谢酶功能影响肿瘤细胞的基因表达、能量代谢、分子调控等过程，进而介导肿瘤的生长、迁移和侵袭，加剧恶性癌细胞生物学特征。本文通过对PGK1的结构、功能及其与肿瘤的关系进行综述，阐明PGK1在肿瘤进展中的重要作用，为靶向PGK1进行药物开发提供理论基础。
Abstract: Phosphoglycerate kinase 1 (PGK1) is the first key metabolic enzyme to produce ATP during glycoly-sis and is involved in the glycolysis pathway of tumors. PGK1 can not only affect tumor growth as a metabolic enzyme, but also affect gene expression, energy metabolism, molecular regulation and other processes of tumor cells through its non-metabolic enzyme function, thus mediating tumor growth, migration and invasion, and exacerbating the biological characteristics of malignant cancer cells. In this paper, the structure, function and relationship between PGK1 and tumor were re-viewed to clarify the important role of PGK1 in tumor progression and provide theoretical basis for drug development targeting PGK1.
文章引用：李钰婵, 张薇, 杨淑梅, 兀威. PGK1在肿瘤中的研究进展[J]. 临床医学进展, 2022, 12(9): 8521-8528. https://doi.org/10.12677/ACM.2022.1291230

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Fu, Q. and Yu, Z. (2020) Phosphoglycerate Kinase 1 (PGK1) in Cancer: A Promising Target for Diagnosis and Therapy. Life Sciences, 256, Article ID: 117863. [Google Scholar] [CrossRef] [PubMed]
[3] Fiorillo, A., Petrosino, M., Ilari, A., et al. (2018) The Phospho-glycerate Kinase 1 Variants Found in Carcinoma Cells Display Different Catalytic Activity and Conformational Stability Compared to the Native Enzyme. PLOS ONE, 13, e0199191. [Google Scholar] [CrossRef] [PubMed]
[4] Danshina, P.V., Geyer, C.B., Dai, Q., et al. (2010) Phospho-glycerate Kinase 2 (PGK2) Is Essential for Sperm Function and Male Fertility in Mice. Biology of Reproduction, 82, 136-145. [Google Scholar] [CrossRef] [PubMed]
[5] Hu, H., Zhu, W., Qin, J., et al. (2017) Acetylation of PGK1 Promotes Liver Cancer Cell Proliferation and Tumorigenesis. Hepatology, 65, 515-528. [Google Scholar] [CrossRef] [PubMed]
[6] Vas, M., Varga, A. and Gráczer, E. (2010) Insight into the Mechanism of Domain Movements and Their Role in Enzyme Function: Example of 3-Phosphoglycerate Kinase. Current Protein & Peptide Science, 11, 118-147. [Google Scholar] [CrossRef] [PubMed]
[7] Sun, S., Liang, X., Zhang, X., Liu, T., Shi, Q., Song, Y., Jiang, Y., Wu, H., Jiang, Y., Lu, X. and Pang, D. (2015) Phosphoglycerate Kinase-1 Is a Predictor of Poor Survival and a Novel Prognostic Biomarker of Chemoresistance to Paclitaxel Treatment in Breast Cancer. British Journal of Cancer, 112, 1332-1339. [Google Scholar] [CrossRef] [PubMed]
[8] Xu, D., Shao, F., Bian, X., Meng, Y., Liang, T. and Lu, Z. (2021) The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies. Cell Metabo-lism, 33, 33-50. [Google Scholar] [CrossRef] [PubMed]
[9] Lu, Z. and Hunter, T. (2018) Metabolic Kinases Moonlighting as Protein Kinases. Trends in Biochemical Sciences, 43, 301-310. [Google Scholar] [CrossRef] [PubMed]
[10] Li, X., Zheng, Y. and Lu, Z. (2016) PGK1 Is a New Member of the Protein Kinome. Cell Cycle, 15, 1803-1804. [Google Scholar] [CrossRef] [PubMed]
[11] Li, X., Jiang, Y., Meisenhelder, J., et al. (2016) Mitochon-dria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Molecular Cell, 61, 705-719. [Google Scholar] [CrossRef] [PubMed]
[12] Qian, X., Li, X., Shi, Z., et al. (2019) PTEN Suppresses Glycol-ysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1. Molecular Cell, 76, 516-527.e7. [Google Scholar] [CrossRef] [PubMed]
[13] Ahmad, S.S., Glatzle, J., Bajaeifer, K., et al. (2013) Phospho-glycerate Kinase 1 as a Promoter of Metastasis in Colon Cancer. International Journal of Oncology, 43, 586-590. [Google Scholar] [CrossRef] [PubMed]
[14] Lowy, A.M., Clements, W.M., Bishop, J., et al. (2006) β-Catenin/Wnt Signaling Regulates Expression of the Membrane Type 3 Matrix Metalloproteinase in Gastric Cancer. Cancer Research, 66, 4734-4741. [Google Scholar] [CrossRef] 
[15] Li, X., Qian, X., Jiang, H., et al. (2018) Nuclear PGK1 Al-leviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication. Molecular Cell, 72, 650-660.e8. [Google Scholar] [CrossRef] [PubMed]
[16] 李小龙. 人白细胞抗原分子B~*5801结构研究及磷酸甘油酸激酶与特拉唑嗪复合物结构研究[D]: [博士学位论文]. 合肥: 中国科学技术大学, 2016.
[17] Tang, W., Wu, Y., Qi, X., et al. (2021) PGK1-Coupled HSP90 Stabilizes GSK3β Expression to Regulate the Stemness of Breast Cancer Stem Cells. Cancer Biology and Medicine, 19, 486-503. [Google Scholar] [CrossRef] [PubMed]
[18] Katoh, M. and Katoh, M. (2009) Integrative Genomic Analyses of CXCR4: Transcriptional Regulation of CXCR4 Based on TGFβ, Nodal, Activin Signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 Transcription Factors. International Journal of Oncology, 36, 415-420. [Google Scholar] [CrossRef] [PubMed]
[19] Dayan, F., Roux, D., Brahimi-Horn, M.C., et al. (2006) The Oxygen Sensor Factor-Inhibiting Hypoxia-Inducible Factor-1 Controls Expression of Distinct Genes through the Bifunctional Transcriptional Character of Hypoxia-Inducible Factor-1α. Cancer Research, 66, 3688-3698. [Google Scholar] [CrossRef] 
[20] Semenza, G.L. (2010) Defining the Role of Hypox-ia-Inducible Factor 1 in Cancer Biology and Therapeutics. Oncogene, 29, 625-634. [Google Scholar] [CrossRef] [PubMed]
[21] Tang, S.-W., Chang, W.-H., Su, Y.-C., et al. (2009) MYC Pathway Is Activated in Clear Cell Renal Cell Carcinoma and Essential for Proliferation of Clear Cell Renal Cell Carcinoma Cells. Cancer Letters, 273, 35-43. [Google Scholar] [CrossRef] [PubMed]
[22] Xu, D., Aka, J.A., Wang, R., et al. (2017) 17beta-Hydroxysteroid Dehydrogenase Type 5 Is Negatively Correlated to Apoptosis Inhibitor GRP78 and Tumor-Secreted Protein PGK1, and Modulates Breast Cancer Cell Viability and Proliferation. The Journal of Steroid Biochemistry and Molecular Biology, 171, 270-280. [Google Scholar] [CrossRef] [PubMed]
[23] Shaw, J., Utz, P., Durand, D., et al. (1988) Identification of a Putative Regulator of Early T Cell Activation Genes. Science, 241, 202-205. [Google Scholar] [CrossRef] [PubMed]
[24] Moeller, B.J., Richardson, R.A. and Dewhirst, M.W. (2007) Hypoxia and Radiotherapy: Opportunities for Improved Outcomes in Cancer Treatment. Cancer and Metastasis Reviews, 26, 241-248. [Google Scholar] [CrossRef] [PubMed]
[25] Ameis, H.M., Drenckhan, A., von Loga, K., et al. (2013) PGK1 as Predictor of CXCR4 Expression, Bone Marrow Metastases and Survival in Neuroblastoma. PLOS ONE, 8, e83701. [Google Scholar] [CrossRef] [PubMed]
[26] Zieker, D., Kouml, I., Traub, F., et al. (2008) PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer. Cellular Physiology and Biochemistry, 21, 429-436. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, Y., Yu, G., Chu, H., et al. (2018) Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis. Molecular Cell, 71, 201-215.e7. [Google Scholar] [CrossRef] [PubMed]
[28] Qian, X., Li, X., Cai, Q., et al. (2017) Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. Molecular Cell, 65, 917-931.e6. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, S., Jiang, B., Zhang, T., et al. (2015) Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLOS Biology, 13, e1002243. [Google Scholar] [CrossRef] [PubMed]
[30] Yu, T., Zhao, Y., Hu, Z., et al. (2017) MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research, 77, 5782-5794. [Google Scholar] [CrossRef] 
[31] Dong, W. and Wu, X. (2018) Overexpression of Rab11-FIP2 in Colorectal Cancer Cells Promotes Tumor Migration and Angiogenesis through Increasing Secretion of PAI-1. Cancer Cell International, 18, 35. [Google Scholar] [CrossRef] [PubMed]
[32] Xu, C., Wang, J., Xia, X., et al. (2016) Rab11-FIP2 Promotes Colorectal Cancer Migration and Invasion by Regulating PI3K/AKT/MMP7 Signaling Pathway. Biochemical and Bio-physical Research Communications, 470, 397-404. [Google Scholar] [CrossRef] [PubMed]
[33] Dong, W., Qin, G. and Shen, R. (2016) Rab11-FIP2 Promotes the Metastasis of Gastric Cancer Cells: Rab11-FIP2 Promotes the Metastasis of Gastric Cancer Cells. International Journal of Cancer, 138, 1680-1688. [Google Scholar] [CrossRef] [PubMed]
[34] Dong, W., Li, H. and Wu, X. (2019) Rab11-FIP2 Suppressed Tumor Growth via Regulation of PGK1 Ubiquitination in Non-Small Cell Lung Cancer. Biochemical and Biophysical Research Communications, 508, 60-65. [Google Scholar] [CrossRef] [PubMed]
[35] Cai, Q., Wang, S., Jin, L., et al. (2019) Long Non-Coding RNA GBCDRlnc1 Induces Chemoresistance of Gallbladder Cancer Cells by Activating Autophagy. Molecular Cancer, 18, 82. [Google Scholar] [CrossRef] [PubMed]
[36] Chu, Z., Huo, N., Zhu, X., et al. (2021) FOXO3A-Induced LINC00926 Suppresses Breast Tumor Growth and Metastasis through Inhibition of PGK1-Mediated Warburg Effect. Molecular Therapy, 29, 2737-2753. [Google Scholar] [CrossRef] [PubMed]
[37] Liu, S.K., Song, L.L., Yao, H.R. and Zhang, L. (2022) HPV16 E6/E7 Stabilize PGK1 Protein by Reducing Its Poly- Ubiquitination in Cervical Cancer. Cell Biology International, 46, 370-380. [Google Scholar] [CrossRef] [PubMed]
[38] Nie, H., Ju, H., Fan, J., et al. (2020) O-GlcNAcylation of PGK1 Coordinates Glycolysis and TCA Cycle to Promote Tumor Growth. Nature Communications, 11, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[39] 张乃文. PGK1及其赖氨酸琥珀酰化修饰在肾细胞癌中的作用及其相关机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2018.
[40] Wang, J., Wang, J., Dai, J., et al. (2007) A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer. Cancer Research, 67, 149-159. [Google Scholar] [CrossRef] 
[41] Liang, C., Shi, S., Qin, Y., et al. (2020) Localisation of PGK1 Determines Metabolic Phenotype to Balance Metastasis and Proliferation in Patients with SMAD4-Negative Pan-creatic Cancer. Gut, 69, 888-900. [Google Scholar] [CrossRef] [PubMed]
[42] Goldstein, M. and Kastan, M.B. (2015) The DNA Damage Re-sponse: Implications for Tumor Responses to Radiation and Chemotherapy. Annual Review of Medicine, 66, 129-143. [Google Scholar] [CrossRef] [PubMed]
[43] Li, L., Bai, Y., Gao, Y., et al. (2021) Systematic Analy-sis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. Disease Mark-ers, 2021, Article ID: 7711151. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, J., Ying, G., Wang, J., et al. (2010) Characterization of Phos-phoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progres-sion. Cancer Research, 70, 471-480. [Google Scholar] [CrossRef] 
[45] Shichijo, S., Azuma, K., Komatsu, N., et al. (2004) Two Proliferation-Related Proteins, TYMS and PGK1, Could Be New Cytotoxic T Lymphocyte-Directed Tumor-Associated Antigens of HLA-A2+ Colon Cancer. Clinical Cancer Research, 10, 5828-5836. [Google Scholar] [CrossRef] 

为你推荐